In this issue:
Outpatient intravenous diuretics for worsening HF
Comparison of HF risk scores for predicting mortality and re-admission
Prognosis of transthyretin cardiac amyloidosis without HF symptoms
ARNI prescription at hospital discharge in HFREF
CV complications of ICIs
ASP and HF progression in ARVC
Treatment response in recentonset nonischaemic vs. ischaemic HFREF
Glycaemic markers and HF subtypes
Predicting survival after fully magnetically levitated LVAD implantation
Please login below to download this issue (PDF)